Article
ANKRD26 is a new regulator of type I cytokine receptor signaling in normal and pathological hematopoiesis
2022-09-03
Abstract excerpt
<h4>ABSTRACT</h4> Sustained ANKRD26 expression associated with germline ANKRD26 mutations causes Thrombocytopenia 2 (THC2), an inherited platelet disorder associated with leukemia predisposition. Some of those patients present also erythrocytosis and/or leukocytosis. Using multiple human-relevant in vitro models (cell lines, primary patient cells and patient-derived iPSCs) we demonstrate for the first time that...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 31d4e078-3cbb-50b4-98cc-fffd03b46231
- DOI
- 10.1101/2022.09.01.506160
